The Novel Use of Magtrace in Chest Masculinizing Transgender Top Surgery
oleh: Jaimie L. Bryan, BS, MD, Lisa R. Spiguel, MD, Kelly M. Herremans, MD, Sabrina H. Han, BS, Jordan A. McKean, MD, Sarah Sorice-Virk, MD
| Format: | Article |
|---|---|
| Diterbitkan: | Wolters Kluwer 2023-12-01 |
Deskripsi
Summary:. Chest masculinization is the most common surgery performed in transgender men, and although incidence of occult cancer is lower than in cis-gender women receiving mastectomy or reduction mammoplasties, the incidence of high-risk lesions is comparable. In patients with concerns for occult malignancy, Magtrace is a nonradioactive tracer available to assist management for its delayed sentinel lymph node mapping capabilities. We present the first case report using Magtrace before masculinizing mastectomies in a transgender man.